Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04112784 · ClinicalTrials.gov registry record

Desaturation Validation of INVSENSOR00039

A clinical trial of Healthy, sponsored by Masimo Corporation.

Completed
Registry status
38
Enrollment target
1
Study location

NCT04112784: Completed study of Healthy, sponsored by Masimo Corporation.

NCT04112784 is a study of Healthy that has completed, run by Masimo Corporation. The registered enrollment target is 38 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04112784, a study of Healthy, has completed, sponsored by Masimo Corporation.

COMPLETED
Registry status
38 participants
Enrollment target
1
Study location

Study Summary

This study is designed to compare the accuracy of a noninvasive measurement of oxygen saturation compared to reference values obtained by a laboratory blood gas analyzer. Arterial blood samples will be collected from healthy adult subjects while undergoing a desaturation procedure wherein the concentration of oxygen inhaled is slowly reduced. The subject will then be returned to breathing room air.

Primary Outcome

Performance of the sensors will be determined by comparing the noninvasive oxygen saturation measurement (SpO2) of the pulse oximeter sensors to the arterial oxygen saturation (SaO2) value obtained from a reference blood sample and calculating the Accuracy root square mean (ARMS) value.

Conditions Studied

Healthy

Interventions

  • DEVICE INVSENSOR00039

Study Locations (1)

California

  • Masimo Corporation - Irvine

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2019-09-17
Est. Completion 2019-10-09
Masimo Corporation

96 total trials

What the finished NCT04112784 record still lists

NCT04112784 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which INVSENSOR00039 is the first listed.

NCT04112784 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04112784 about?

NCT04112784 is a clinical study titled "Desaturation Validation of INVSENSOR00039". This study is designed to compare the accuracy of a noninvasive measurement of oxygen saturation compared to reference values obtained by a laboratory blood gas analyzer. Arterial blood samples will be collected from healthy adult subjects while undergoing a desaturation procedure wherein the concen...

What is the current status of trial NCT04112784?

This trial is currently completed. The enrollment target is 38 participants. The study started on 2019-09-17. Estimated completion is 2019-10-09.

What conditions does trial NCT04112784 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT04112784?

The interventions under investigation include: INVSENSOR00039 (DEVICE).

Who is sponsoring clinical trial NCT04112784?

This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04112784 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04112784's enrollment target sits among peer trials

38 582nd of 1090 higher than 502 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01684904 · 38 participants · NA

    Proton Therapy for Esophageal Cancer

  • NCT03310879 · 38 participants · Phase 2

    Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6

  • NCT03896269 · 38 participants · Phase 1

    CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

  • NCT04085315 · 38 participants · Phase 1

    Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT04112784, the US trial registry maintained by the National Library of Medicine. NCT04112784 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.